CIK 0001069530
- Non-accelerated filer
- Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911911336
- Phone
- +1 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 4 Open-market buy 10% owner bought 5,000 shares at $8.42 ($42,100)
- 4 Open-market buy 10% owner bought 11,500 shares at $8.51 ($97,865)
- 4 Open-market buy 10% owner bought 32,422 shares at $8.67 ($281,099)
- 4/A Open-market sale President and CEO sold 50,000 shares at an average $8.91 ($445,500)
- 4 Open-market buy 10% owner bought 10,447 shares at $8.70 ($90,889)
- 4 Open-market sale President and CEO sold 50,000 shares at an average $8.91 ($445,500)
- 4 Open-market sale Vice President and CFO sold 10,000 shares at $8.17 ($81,700)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 50,000 shares at an average $8.39 ($419,500)
- 4 Open-market buy 10% owner bought 8,000 shares at $8.03 ($64,240)
- 4 Open-market buy 10% owner bought 38,096 shares at $8.03 ($305,911)
- 4 Open-market sale Vice President and CFO sold 10,000 shares at $8.23 ($82,300)
- 4 Open-market buy Chief Financial Officer bought 4,658 shares at $4.43 ($20,635)
- 4 Open-market buy Chief Operating & Med. Officer bought 4,516 shares at $4.43 ($20,006)
Page 22 of 30 · 591 filings